Shares of Baxter International (BAX) lost 0.9% in Tuesday's little inspiring trading session. The global diversified healthcare company officially announced the acquisition of Gambro for $4 billion in cash. In recent weeks shares of Baxter rose to the highest levels in 2012 as rumors about a possible deal between the companies hit the news wires.
The Deal
Baxter International announced on Tuesday that it has agreed to buy Swedish based Gambro for roughly $4.0 billion, or 26.5 billion SEK in cash.
The deal fits within Baxter's strategy of saving and sustaining human lives. The transaction creates a complementary dialysis portfolio of chronic and acute kidney diseases. The deal allows Baxter to capitalize on attractive global dialysis fundamentals. The global dialysis market grows at a compounded annual growth rate of 5-6%.
No comments:
Post a Comment